XML 52 R41.htm IDEA: XBRL DOCUMENT v3.20.2
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of anti-dilutive shares - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Schedule of anti-dilutive shares [Abstract]        
Net income available to common stockholders $ 4,753,603 $ 961,042 $ 6,857,988 $ 11,144,342
Interest expense on convertible notes 105,385 348,493
Amortization of discount on notes payable 528,464 707,286
Diluted net income (loss) available to common stockholders $ 4,753,603 $ 1,594,891 $ 6,857,988 $ 12,200,121
Income per share:        
Basic (in Dollars per share) $ 0.07 $ 0.02 $ 0.10 $ 0.19
Diluted (in Dollars per share) $ 0.06 $ 0.03 $ 0.09 $ 0.20
Weighted average shares outstanding:        
Basic (in Shares) 70,473,351 59,307,404 70,184,071 58,023,685
Diluted (in Shares) [1] 74,848,239 62,532,510 73,524,209 62,050,032
[1] Please refer to Earnings Per Share section for further details